⌘K
Loading ticker…
As of 2026-08-24, Jazz Pharmaceuticals, Inc. (JAZZ) has a 3-month relative strength percentile of 60 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 63. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 2.8%, relative volume 0.53×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
JAZZ is in a stage 2 uptrend, week 12. Currently in a 14-day base; basing ADR 2.9% (broad 2.8%). VCP detected: no. RS line below base-start high. Distance from 50d / 200d: 3.8% / 26.8%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
JAZZ appears in 1 ETF as of Jun 2026: HWSM at 1.16% weight, $32K notional.
Held by 71 ETFs · $1.4B across latest filings · largest weight 3.43% (PJP).
Top 1 by value, from SEC N-PORT-P filings dated Jun 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| HWSM | 1.16% | $32K | +0.14 pp |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | JAZZ Jan avg: -1.03% median: -0.95% win: 25% σ: 1.83% n: 4 2022-04-12 → 2026-07-31 | JAZZ Feb avg: 4.36% median: 6.15% win: 50% σ: 13.16% n: 4 2022-04-12 → 2026-07-31 | JAZZ Mar avg: -2.13% median: 0.38% win: 50% σ: 7.83% n: 4 2022-04-12 → 2026-07-31 | JAZZ Apr avg: -2.08% median: -4.00% win: 40% σ: 6.06% n: 5 2022-04-12 → 2026-07-31 | JAZZ May avg: -2.28% median: -6.58% win: 20% σ: 10.59% n: 5 2022-04-12 → 2026-07-31 | JAZZ Jun avg: 0.49% median: 1.41% win: 60% σ: 3.01% n: 5 2022-04-12 → 2026-07-31 | JAZZ Jul avg: 4.30% median: 4.93% win: 100% σ: 2.93% n: 5 2022-04-12 → 2026-07-31 | JAZZ Aug avg: 6.51% median: 7.56% win: 75% σ: 5.40% n: 4 2022-04-12 → 2026-07-31 (current) | JAZZ Sep avg: -6.15% median: -6.83% win: 25% σ: 7.49% n: 4 2022-04-12 → 2026-07-31 | JAZZ Oct avg: 2.30% median: 1.60% win: 50% σ: 4.67% n: 4 2022-04-12 → 2026-07-31 | JAZZ Nov avg: 10.24% median: 9.81% win: 75% σ: 14.38% n: 4 2022-04-12 → 2026-07-31 | JAZZ Dec avg: 0.79% median: 1.41% win: 75% σ: 3.24% n: 4 2022-04-12 → 2026-07-31 |